India Business News: NEW DELHI: Mumbai-based JB Chemicals will acquire select ophthalmology brands from Swiss major Novartis for $116 million (Rs 964 crore) to enter the h.
Business News: Novartis plans to divest its Indian eyecare portfolio to JB Chemicals, adding to the list of MNCs reducing exposure to the Indian market. The move ali
Mumbai-based JB Chemicals & Pharmaceuticals Ltd, which is majority-owned by private equity firm KKR, is looking to acquire the Indian eyecare portfolio of drug major ..
Business News: Novartis plans to divest its Indian eyecare portfolio to JB Chemicals, adding to the list of MNCs reducing exposure to the Indian market. The move ali
“We believe that Ciplas Pithampur facility was inspected in February and post that, they got an OAI in August and post that, it has escalated to a warning letter. We believe that it is unlikely that this will escalate further to import alerts, though this may take some time to resolve.”